Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

Podrobná bibliografie
Hlavní autoři:	Keshav, S, Ungashe, S, Zheng, W, Belker, P, Wright, K, Schall, T
Médium:	Conference item
Vydáno:	2007

Podobné jednotky

Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease
Autor: Bekker, P, a další
Vydáno: (2007)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
Autor: Walters, M, a další
Vydáno: (2010)

MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B
Autor: Ungashe, S, a další
Vydáno: (2008)

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.
Autor: Satish Keshav, a další
Vydáno: (2013-01-01)

PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
Autor: Bekker, P, a další
Vydáno: (2009)

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
Autor: Keshav, S, a další
Vydáno: (2009)

PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease
Autor: Keshav, S, a další
Vydáno: (2007)

Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial
Autor: Bekker, P, a další
Vydáno: (2008)

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease
Autor: Bekker, P, a další
Vydáno: (2007)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
Autor: Wei, Z, a další
Vydáno: (2005)

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation
Autor: Ewa A. Bartko, a další
Vydáno: (2023-05-01)

Traficet-EN, an Oral CCR9-Specific Antagonist, induces high levels of remission in the open-label Phase of PROTECT-1 in Crohn's Disease
Autor: Bekker, P, a další
Vydáno: (2008)

Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
Autor: Bekker, P, a další
Vydáno: (2008)

CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.
Autor: Wendt, E, a další
Vydáno: (2015)

CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
Autor: Wendt E, a další
Vydáno: (2015-04-01)

Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
Autor: Hui Zhang, a další
Vydáno: (2021-07-01)

Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
Autor: Zhehua Shao, a další
Vydáno: (2022-05-01)

Antagonist of chemokine receptors CCR1 and CCR3
Autor: Ammit Alaina, a další
Vydáno: (2000-11-01)

Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.
Autor: Daniel Clark Files, a další
Vydáno: (2022-06-01)

Milligram production and biological activity characterization of the human chemokine receptor CCR3.
Autor: Mingqing Wang, a další
Vydáno: (2013-01-01)

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
Autor: Kathleen M C Sullivan, a další
Vydáno: (2023-01-01)

Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation
Autor: Julia M. Laufer, a další
Vydáno: (2019-10-01)

Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice.
Autor: Rodrigo Guabiraba, a další
Vydáno: (2010-01-01)

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells.
Autor: Greaves, D, a další
Vydáno: (1997)

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
Autor: Yamaguchi Kazuhiro, a další
Vydáno: (2009-08-01)

Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20
Autor: David Jonathan Wasilko, a další
Vydáno: (2020-06-01)

Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion.
Autor: Alex de Voux, a další
Vydáno: (2013-01-01)

Identification and Expression Profiling Analysis of the Cation/Ca2+ Exchanger (CCX) Gene Family: Overexpression of SlCCX1-LIKE Regulates the Leaf Senescence in Tomato Flowering Phase
Autor: Jiao Li, a další
Vydáno: (2021-06-01)

Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
Autor: Sancho, M, a další
Vydáno: (2006)

The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions
Autor: Oliveira S.H.P., a další
Vydáno: (2003-01-01)

CCR9 Antagonists in the Treatment of Ulcerative Colitis
Autor: Pirow Bekker, a další
Vydáno: (2015-01-01)

A systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte trafficking.
Autor: Noah J Tubo, a další
Vydáno: (2012-01-01)

Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.
Autor: Silvia Affò, a další
Vydáno: (2015-01-01)

Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis
Autor: Alessia G. Liner, a další
Vydáno: (2025-01-01)

Activation of CCR2+ human proinflammatory monocytes by human herpesvirus-6B chemokine N-terminal peptide.
Autor: Clark, D, a další
Vydáno: (2013)

Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
Autor: Jiaqi Yang, a další
Vydáno: (2021-03-01)

The chemokine receptor CCR5: multi-faceted hook for HIV-1
Autor: Natacha Faivre, a další
Vydáno: (2024-01-01)

In Silico Identification of Cholesterol Binding Motifs in the Chemokine Receptor CCR3
Autor: Evan van Aalst, a další
Vydáno: (2021-07-01)

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
Autor: Daniele Di Marino, a další
Vydáno: (2023-10-01)

Chemokine receptor CCR3 is important for migration of mast cells in neurofibroma
Autor: Wei-Chun Tai, a další
Vydáno: (2010-12-01)